Practice Guideline
doi: 10.1093/annonc/mdm016.
Recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
- PMID: 17491064
- DOI: 10.1093/annonc/mdm016
Item in Clipboard
Practice Guideline
Recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol.
2007 Apr.
Free article
Erratum in
- Ann Oncol. 2008 May;19(5):1027-9
No abstract available
Similar articles
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).Ann Oncol. 2005;16 Suppl 1:i10-2. doi: 10.1093/annonc/mdi816. Ann Oncol. 2005. PMID: 15888735 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2011 Sep;22 Suppl 6:vi25-30. doi: 10.1093/annonc/mdr372. Ann Oncol. 2011. PMID: 21908499 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2008 May;19 Suppl 2:ii11-3. doi: 10.1093/annonc/mdn072. Ann Oncol. 2008. PMID: 18456744 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2009 May;20 Suppl 4:15-8. doi: 10.1093/annonc/mdp115. Ann Oncol. 2009. PMID: 19454439 Review. No abstract available.
-
[Treatment guideline for advanced or recurrent breast cancer].Nihon Rinsho. 2000 Apr;58 Suppl:237-45. Nihon Rinsho. 2000. PMID: 11026001 Review. Japanese. No abstract available.
Cited by
-
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.J Patient Cent Res Rev. 2014 Spring;1(2):85-92. doi: 10.17294/2330-0698.1017. J Patient Cent Res Rev. 2014. PMID: 25914894 Free PMC article.
-
Trastuzumab : in HER2 and hormone receptor co-positive metastatic breast cancer.Drugs. 2007;67(18):2781-9. doi: 10.2165/00003495-200767180-00009. Drugs. 2007. PMID: 18062723 Review.
-
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer.Biologics. 2008 Mar;2(1):61-5. doi: 10.2147/btt.s1713. Biologics. 2008. PMID: 19707428 Free PMC article.
-
Different types of tumor vessels in breast cancer: morphology and clinical value.Springerplus. 2015 Sep 17;4:512. doi: 10.1186/s40064-015-1293-z. eCollection 2015. Springerplus. 2015. PMID: 26405632 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
